Reducing these with docosahexaenoic acid (DHA) abrogated insulin-stimulated FASN expression, suggesting insulin promotes FASN expression in breast cancer by upregulating SREBP through the Akt pathway [148]. The gene discussed is FASN; the disease is breast cancer.